CV-03
/ CUREVERSE
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 18, 2026
Discovery of highly selective, orally available small-molecule DDR1 inhibitors that reprogram the collagen-DDR1 tumor microenvironment
(AACR 2026)
- "Abstract is embargoed at this time."
Biomarker • Late-breaking abstract • Tumor microenvironment • Oncology • DDR1
1 to 1
Of
1
Go to page
1